爱尔眼科医院集团是知名全球连锁眼科医疗机构，IPO上市医疗机构(股票代码: 300015，2015年入选沪深300指数股)。截至2019年，已在中国大陆30个省市区建立300余家专业眼科医院，覆盖全国医保人口超过70%，年门诊量超过1000  万人。并且，在美国、欧洲和中国香港开设有80余家眼科医院。

　　Aier eye hospital group is a well-known global chain of eye hospitals, and is also China's first IPO listed medical institution (stock code: 300015, one of the CSI 300 index selected in 2015). As of 2019, Aier Eye Hospital Group has established more than 300 specialized eye hospitals covering 30 provinces and extended our services to 70% of insured population all over the country with over 6.5 million outpatient visits annually. Recently, There are more than 80 ophthalmic branches in the United States, Europe and Hongkong,China.

　　爱尔眼科致力于引进和吸收国际先进的眼科技术与医疗管理理念，以专业化、规模化、科学化为发展战略，推动中国眼科医疗事业的发展。

　　Aier is committed to the parallel introduction and absorption of world-leading ophthalmic technology and management concept, with professionalism, scale and science as its strategy to advance the development of China's ophthalmic medical care.

　　金华爱尔眼科医院集团投资建设的连锁医院之一，医院建筑面积近4000平方米，床位50张，手术室4间，医院设有屈光、白内障、青光眼、干眼、综合眼病、医学验光配镜等专业科室，分科精细，建制齐全，专病专治。

　　医院拥有多台国际先进的大型医疗设备，如德国蔡司SMILE全飞秒、德国AMARIS准分子激光、OCULUS Keratograph 眼表综合分析仪、爱尔康玻切机、爱尔康Centurion白内障超声乳化仪、ELLEX前节激光、SOLARI脉冲光干眼治疗仪、罗兰电生理、KOWA眼底照相荧光造影仪、眼科专用A/B超、德国蔡司OCT、德国蔡司视野计等。